Increased uptake of iodine-123-BMIPP in chronic ischemic heart disease: Comparison with fluorine-18-FDG SPECT

Journal of Nuclear Medicine

Volumn 39, Issue 2, 1998, Pages 255-260

  Sloof, Gerrit W ^a   Visser, Frans C ^b   Bax, Jeroen J ^b   Van Lingen, Arthur ^b   Eersels, Jos ^b   Knapp Jr , Furn F ^b   Teule, Gerrit J J ^b  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b NONE

Author keywords

Chronic ischemic myocardium; Fluorine 18 FDG; Iodine 123 BMIPP

Indexed keywords

15 (4 IODOPHENYL) 3 METHYLPENTADECANOIC ACID I 123; ACIPIMOX; FLUORODEOXYGLUCOSE F 18; HUMAN SERUM ALBUMIN; THALLIUM 201;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL PROTOCOL; CONTROLLED STUDY; FEMALE; HEART INFARCTION; HEART MUSCLE BLOOD FLOW; HEART MUSCLE ISCHEMIA; HEART MUSCLE PERFUSION; HUMAN; INTERMETHOD COMPARISON; INTRAVENOUS DRUG ADMINISTRATION; ISCHEMIC HEART DISEASE; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

AGED; CHRONIC DISEASE; CORONARY CIRCULATION; CORONARY DISEASE; FATTY ACIDS; FEMALE; FLUORODEOXYGLUCOSE F18; HEART; HUMANS; IODINE RADIOISOTOPES; IODOBENZENES; MALE; MIDDLE AGED; RADIOPHARMACEUTICALS; THALLIUM RADIOISOTOPES; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 0031893405     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. 18F]FDG-PET and rest thallium-201 SPECT for the detection of myocardial viability. J Nucl Med 1995;36:176-179.
2. Martin WH, Delbeke D, Patton JA, et al. FDG-SPECT: correlation with FDG-PET. J Nucl Med 1995;36:988-995.
3. Bax JJ, Visser FC, Blanksma PK, et al. Comparison of myocardial uptake of fluorine-18-fluorodeoxyglucose imaged with PET and SPECT in dyssynergic myocardium. J Nucl Med 1996;37:1631-1636.
4. Opie LH. Metabolism of the heart in health and disease. Part I. Am Heart J 1968;76:685-698.
5. Van der Vusse GJ, Glatz JFC, Stam HCG, Reneman RS. Fatty acid homeostasis in the normoxic and ischemic heart. Physiol Rev 1992;72:881-940.
6. Knapp FF Jr, Kropp J. Iodine-123-labeled fatty acids for myocardial single-photon emission tomography: current status and future perspectives. Eur J Nucl Med 1995;22:361-381.
7. Knapp FF Jr, Kropp J, Franken PR, et al. Pharmacokinetics of radioiodinated fatty acid myocardial imaging agents in animal and human studies. Invited review. Q J Nucl Med 1996;40:252-269.
8. 123I-β-methyl-iodo-phenyl pentadecanoic acid. Eur J Nucl Med 1994;21:283-291.
9. Knapp FF Jr, Franken P, Kropp J. Cardiac SPECT with iodine-123-labeled fatty acids: evaluation of myocardial viability with BMIPP. J Nucl Med 1995;36:1022-1030.
10. 201T1-SPECT images. Eur J Nucl Med 1996;23:917-923.
11. Nohara R, Okuda K, Ogino M, et al. Evaluation of myocardial viability with iodine-123-BMIPP in a canine model. J Nucl Med 1996;37:1403-1407.
12. Tamaki N, Tadamura E, Kawamoto M, et al. Decreased uptake of iodinated branched fatty acid analog indicates metabolic alterations in ischemic myocardium. J Nucl Med 1995;36:1974-1980.
13. Schwaiger M, Schelbert HR, Ellison D, et al. Sustained regional abnormalities in cardiac metabolism after transient ischemia in the chronic dog model. J Am Coll Cardiol 1985;6:336-347.
14. Melin JA, Becker LC. Quantitative relationship between global left ventricular thallium uptake and blood flow: effects of propanolol, ouabain, dipyridamole and coronary artery occlusion. J Nucl Med 1986;27:641-652.
15. Knuuti MJ, Yki-Järvinen H, Voipio-Pulkki LM, et al. Enhancement of myocardial [F-18]FDG uptake by a nicotinic acid derivate. J Nucl Med 1994;35:989-998.
16. Van Lingen A, Huijgens PC, Visser FC, et al. Performance characteristics of a 511-keV collimator for imaging positron emitters with a standard gamma camera. Eur J Nucl Med 1992;19:315-321.
17. 123I radioiodination of 15(p-I-phenyl)-9-methyl pentadecanoic acid, a potential myocardial tracer. Eur J Nucl Med 1987;13:159-160.
18. Bax JJ, Visser FC, van Lingen A, et al. Relation between myocardial uptake of thallium-201 chloride and fluorine-18 fluorodeoxyglucose imaged with single-photon emission tomography in normal individuals. Eur J Nucl Med 1995;22:56-60.
19. Bax JJ, Cornel JH, Visser FC, et al. Prediction of recovery of myocardial dysfunction following revascularization: comparison of fluorine-18-fluorodeoxyglucose/thallium-201 SPECT, thallium-201 stress-reinjection SPECT and dobutamine echocardiography. J Am Coll Cardiol 1996;28:558-564.
20. Tamaki N, Kawamoto M, Yonekura Y, et al. Regional metabolic abnormality in relation to perfusion and wall motion in patients with myocardial infarction: assessment with emission tomography using an iodinated branched fatty acid analog. J Nucl Med 1992;33:659-667.
21. Tillisch J, Brunken R., Marshall R., et al. Reversibility of cardiac wall motion abnormalities predicted by positron tomography. N Engl J Med 1986;314:884-888.
22. Tamaki N, Yonekura Y, Yamashita K, et al. Positron emission tomography using fluorine-18-fluorodeoxyglucose in evaluation of coronary bypass grafting. Am Cardiol 1989;64:860-865.
23. Schwaiger M, Hicks R. The clinical role of metabolic imaging of the heart by positron emission tomography. J Nucl Med 1991;32:565-578.
24. Marwick T, Maclntyre WJ, Lafont A, Nemee JJ, Salcedo EE. Metabolic responses of hibernating and infarcted myocardium to revascularization. Circulation 1992;85:1347-1353.
25. Miller DD, Gill JB, Livni E, et al. Fatty acid analog accumulation: a marker of myocyte viability in ischemic-reperfused myocardium. Circ Res 1988;63:681-692.
26. 123I-β-methyl-iodophenyl pentadecanoic acid (BMIPP): comparison of myocardial perfusion and fatty acid utilization in canine myocardial infarction (occlusion and reperfusion model). Eur J Nucl Med 1989;15:341-345.
27. Maes A, Flameng W, Nuyts J, et al. Histological alterations in chronically hypoperfused myocardium: correlation with PET findings. Circulation 1994;90:735-745.
28. Depré C, Vanoverschelde J-LJ, Melin JA, et al. Structural and metabolic correlates of the reversibility of chronic left ventricular ischemic dysfunction in humans. Am J Physiol 1995;268:H1265-H1275.
29. Gropler RJ, Siegel B, Sampathkumaran K, et al. Dependence of recovery of contractile function on maintenance of oxidative metabolism after infarction. J Am Coll Cardiol 1992;19:989-997.
30. Gropler RJ, Geltman EM, Sampathkumaran K, et al. Comparison of carbon-11-acetate with fluorine-18-fluorodeoxyglucose for delineating viable myocardium by positron emission tomography. J Am Coll Cardiol 1993;22:1587-1597.
31. Yamamichi Y, Kusuoka H, Morishita K, et al. Metabolism of iodine-123-BMIPP in perfused rat hearts. J Nucl Med 1995;36:1043-1050.
32. Fujibayashi Y, Nohara R, Hosokawa R, et al. Metabolism and kinetics of iodine-123-BMIPP in canine myocardium. J Nucl Med 1996;37:757-761.
33. Tamaki N, Kawamoto M, Yonekura Y, et al. Assessment of fatty acid metabolism using I-123 branched fatty acid: comparison with positron emission tomography. Ann Nucl Med 1993;7(suppl):SII-41-SII-47.
34. Fujibayashi Y, Yonekura Y, Takemura Y, et al. Myocardial accumulation of iodinated beta-methyl-branched fatty acid analog, iodine-125-15-(p-iodophenyl)-3-(R,S)-methyl-pentadecanoic acid (BMIPP), in relation to ATP concentration. J Nucl Med 1990;31:1818-1822.
35. Hosokawa R, Nohara R, Fujibayashi Y, et al. Metabolic fate of iodine-123-BMIPP in canine myocardium after administration of etomoxir. J Nucl Med 1996;37:1836-1840.
36. Tateno M, Tamaki N, Yukihiro M, et al. Assessment of fatty acid uptake in ischemic heart disease without myocardial infarction. J Nucl Med 1996;37:1981-1985.
37. 123I-phenyl)-pentadecanoic acid uptake in persisting defects on thallium-201 tomography in myocardial infarction. J Nucl Med 1991;32:1353-1357.
38. Marie PY, Karcher G, Danchin N, et al. Thallium-201 rest-reinjection and Iodine-123-MIHA imaging of myocardial infarction: analysis of defect reversibility. J Nucl Med 1995;36:1561-1568.
39. Jonas M, Brandau W, Vollet B, et al. Simultaneous evaluation of fatty acid metabolism and myocardial flow in an explanted heart. J Nucl Med 1996;37:1990-1994.
40. Schwaiger M, Hicks R. Regional heterogeneity of cardiac substrate metabolism? J Nucl Med 1990;31:1757-1760.
41. Louie EK, Hariman RJ, Krahmer RL, Goldbaum AF, Prechel DP, Ferguson JL. Heterogeneity of reperfusion after reversible regional myocardial ischemia in a canine model. Am Heart J 1993;126:514-520.